Skip to main content
. 2021 Jul 28;16:330. doi: 10.1186/s13023-021-01961-8

Table 5.

Changes of CSF routine parameters during 14 months of nusinersen treatment

CSF routine parameter n Baseline median (IQR) 14-month analysis median (IQR) p value
CellCount (MPt/L) 57 1.0 (0.0–2.0) 1.0 (0.15–1.0) n.s
Qalb (× 10–3) 56 4.1 (3.3–6.1) 4.7 (3.7–6.3) 0.000359***
Protein (mg/L) 58 308 (244–419) 345 (283–443) 0.000246***

CSF cerebrospinal fluid, Qalb ratio of serum/CSF albumin, IQR interquartile range, n.s. not significant

***p < 0.001 calculated by Wilcoxon signed-rank test